PRESS RELEASES
Dec 17 09
Regado Biosciences, Inc. Completes $40 Million Series D Financing
Nov 25 09
Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
Nov 12 09
Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
Nov 11 09
Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
Nov 10 09
Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16, 2009
Nov 03 09
Regado Biosciences to Present at the 3rd Annual Canaccord Adams Cardiovascular Conference on November 10, 2009
Oct 27 09
Regado Biosciences to Present at the BIO-Europe Conference 2009 on November 3, 2009
Oct 22 09
Regado Biosciences to Present at the 8th Annual BIO Investor Forum on October 29, 2009
Oct 05 09
Regado Biosciences to Present at the 2009 Japan Biopharma Partnering Conference on October 6, 2009
Sep 17 09
Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
Sep 15, 2009
Regado Biosciences to Present at the Biopharm America 2009 Conference on September 17, 2009
Sep 9, 2009
REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN RADAR (Phase 2b) STUDY OF REG1 ANTICOAGULATION SYSTEM
Sep 4, 2009
REGADO BIOSCIENCES TO PRESENT AT THE THOMAS WEISEL PARTNERS HEALTHCARE CONFERENCE 2009 ON SEPTEMBER 11, 2009
Sep 3, 2009
REGADO BIOSCIENCES TO PRESENT AT THE RODMAN & RENSHAW GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 10, 2009
Aug 31, 2009
REGADO BIOSCIENCES RELEASES POSITIVE PHASE 2A DATA FOR THE REVERSIBLE ANTICOAGULANT SYSTEM REG1 AT THE EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS IN BARCELONA, SPAIN
Aug 24, 2009
REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 1 STUDY OF SUBCUTANEOUSLY ADMINISTERED REG1 ANTICOAGULATION SYSTEM
Jul 20, 2009
REGADO BIOSCIENCES EXPANDS MEDICAL ADVISORY BOARD
Jun 02, 2009
REGADO BIOSCIENCES ESTABLISHES MEDICAL ADVISORY BOARD
Mar 30, 2009
REGADO BIOSCIENCES TO PRESENT AT THE 16TH ANNUAL FUTURE LEADERS IN THE BIOTECH INDUSTRY CONFERENCE
Mar 17, 2009
REGADO BIOSCIENCES SELECTED TO PRESENT AT INSIDEVENTURE’S DEBUT INVESTOR CONFERENCE -
MARCH 25-26, SANTA BARBARA, CALIFORNIA
Feb 12, 2009
REGADO BIOSCIENCES TO PRESENT AT THE 2009 WHARTON HEALTHCARE BUSINESS CONFERENCE
Jan 15, 2009
DR. STEVEN L. ZELENKOFSKE JOINS REGADO BIOSCIENCES AS SENIOR VICE PRESIDENT, CLINICAL AND MEDICAL AFFAIRS AND CHIEF MEDICAL OFFICER
Jan 6, 2009
REGADO BIOSCIENCES TO PRESENT AT THE 27TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Dec 2, 2008
ELLEN MCDONALD JOINS REGADO BIOSCIENCES AS SENIOR VICE PRESIDENT OF BUSINESS OPERATIONS AND CHIEF BUSINESS OFFICER
Dec 1, 2008
REGADO BIOSCIENCES TO PRESENT AT THE PIPER JAFFRAY HEALTH CARE CONFERENCE ON TUESDAY, DECEMBER 2, 2008
Nov 11, 2008
ALEXANDER R. GIAQUINTO, PH.D., JOINS REGADO BIOSCIENCES AS SENIOR VICE PRESIDENT OF REGULATORY AFFAIRS AND QUALITY ASSURANCE
Oct 14, 2008
REGADO BIOSCIENCES COMPLETES PATIENT ENROLLMENT FOR PHASE IIA STUDY OF REG1 ANTICOAGULATION SYSTEM
Sep 2, 2008
REGADO BIOSCIENCES REPORTS CLINICAL RESULTS FOR REG1 ANTICOAGULATION SYSTEM AT EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2008
Aug 4, 2008
DAVID J. MAZZO, PH.D., JOINS REGADO BIOSCIENCES AS PRESIDENT AND CEO
Jun 5, 2008
REGADO BIOSCIENCES ANNOUNCES PUBLICATION IN CIRCULATION OF CLINICAL TRIAL RESULTS OF REG1 ANTICOAGULATION SYSTEM
May 14, 2008
REGADO BIOSCIENCES’ REG1 ANTICOAGULATION SYSTEM STUDY RESULTS PUBLISHED IN THE JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Nov 6, 2007
REGADO BIOSCIENCES PRESENTS PHASE I DATA FOR REG1 ANTICOAGULATION SYSTEM AT AMERICAN HEART ASSOCIATION 2007 SCIENTIFIC SESSIONS
Nov 4, 2007
REGADO BIOSCIENCES PRESENTS POSITIVE DATA FROM REG1 ANTICOAGULATION SYSTEM PHASE Ic STUDY AT AMERICAN HEART ASSOCIATION 2007 SCIENTIFIC SESSIONS
Mar 27, 2007
REGADO BIOSCIENCES COMPLETES $23 MILLION SERIES C FINANCING
|
|
